DOCSLIB.ORG

2-6 May Barcelona, Spain2-6 2-6

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2-6 May Barcelona, Spain2-6 2-6 ISEV2018 I SEV20 18 FINALABSTRA PROGRAMCT BOOK ANNUALP a lau deME C o ng re s sos de BETING arce lona - Fira M o nt juic ANNUALMEETING ANNUALMEETING 2-6 May Barcelona, Spain2-6 2-6 Annual Meeting — ISEV2018 | Barcelona, Spain | 2–6 May 2018 1 1 Table of Contents Letter from the ISEV President 3 Letter from the ISEV IOC Chair 4 Executive Board and Board of Directors 5 International Organizing Committee 6 Palau de Congressos Barcelona – Fira Montjuic Floor Plan 7 General Information 9 Plenary Speakers 11 Program Information 15 Satellite EVents 35 Abstract Directory 38 Sponsor Directory 54 Annual Meeting — ISEV2018 | Barcelona, Spain | 2–6 May 2018 2 Welcome from ISEV President Dear Colleagues, On behalf of the International Society for Extracellular Vesicles (ISEV) Board of Directors and the International Organising Committee (IOC), it is a pleasure to welcome you to ISEV2018. This year, ISEV has teamed up with GEIVEX (Spanish Society for Innovation and Investigation in Extracellular Vesicles, www. geivex.org) to organize ISEV2018. The ISEV2018 IOC, composed of ISEV and GEIVEX board members, had worked hard to prepare an interesting and dynamic program that includes educational sessions, along with the latest advances of the field - representing both fundamental and clinical aspects. In 2018, we will host a record number of attendees at the annual ISEV meeting and this reflects the growing recognition of the field and the numbers of researchers now working on extracellular vesicles. ISEV2018 begins with the Education Day, covering two tracks in “Biology and Technology” and “EVs in Health and Disease”. The main meeting features again this year the ‘Meet the Experts’ and ‘Experts Workshops’ sessions in addition to the national societies session – all aimed at increasing networking amongst our international community. There are satellite sessions covering “Emerging Trends in HIV, NeuroAIDS, Drug Abuse and EVs”, an “exRNA ERCC Workshop”, and a meeting of the ISEV-ISAC-ISTH EV flow cytometry workgroup. This year we introduce sessions including an Early Career Development Session on Academia and Industry in the field of EVs as well as a “Meet the Editors” session featuring presentations from journal editors relevant to the EV field. I would like to thank the members of the IOC, led by Juan M. Falcón-Pérez, for their efforts in making ISEV2018 possible. Also, thanks to the ISEV Board of Directors for their continued commitments to growing and supporting ISEV and serving the community of EV researchers. On behalf of ISEV, we also acknowledge and thank our corporate sponsors who provide essential support for the meeting. Don’t forget to attend the not-to-be-missed Networking Event on Saturday 5th May at 20:15 – a great opportunity to network and socialize with attendees of the meeting. I hope you enjoy all that ISEV2018 has to offer and wish you all the best with your EV research that follows! Regards, Andy Hill, PhD President, ISEV Annual Meeting — ISEV2018 | Barcelona, Spain | 2–6 May 2018 3 Welcome from the International Organizing Committee Chair Dear Colleagues: On behalf of the International Organizing Committee, it is with great pleasure that I welcome you to the the seventh Annual Meeting of the International Society for Extracellular Vesicles. It has been an honor to organize this meeting where scientists from around the globe share the latest knowledge on extracellular vesicles that represent a new paradigm both in cell biology and medicine. They are considered to offer unprecedented opportunities for future applications from new generation diagnostic or prognostic biomarkers to therapeutic applications. The International Society for Extracellular Vesicles (ISEV) was founded in 2011, and as the authoritative international community for extracellular vesicle research, it focuses on all aspects of extracellular vesicle investigations. More than 1000 delegates will attend ISEV2018 presenting over 700 scientific presentations. The annual meeting will feature speakers covering novel and stimulating scientific areas including “Autophagy, Metabolism, Aging”, “Advances in Exosome Biology”, “Environment, Diet & Health”, “Neglected Diseases” and “Tissue Architecture”. A dedicated scientific program with 30 symposium sessions will cover all aspects of EV research from basic research, technological development and clinic applications. The program will be completed by the Meet- the-Expert sessions on “EV-Biobanks”, “EV-Regulatory aspects”, “EV-RNA”, “EV-Biomarkers”, “EV-Immunology”, “EV-Neglected diseases”, “EV-Leukemia (Josep Carreras Foundation)”, “EV-in vivo Imaging”, and the “EV-blood roadmap”. In addition, there will be satellite sessions on Flow Cytometry (joint session with ISAC and ISTH), EV- HIV and RNA-ERCC, as well as, the meeting with the EV-related National Societies. This year also offers sessions to meet the editors of journals, and have the opportunity to listen tips from young EV-successful researchers on academic an industry tracks during the “Young EV Career Development” session. During the congress, ISEV will introduce new developments in EV-based 3D animation and outreach strategies that ISEV is supporting. Be sure to attend the Opening Ceremony and enjoy a performance by tenor Sergi Gimenez Carreras. The networking event on Saturday evening will be held in Cupula at the Arenas de Barcelona with different entertainment options embedded in the cosmopolitan Barcelona´s environment. ISEV is committed to creating a most memorable scientific congress. Through your participation, interest, and support, you will certainly contribute to the success of the meeting and the advancement of novel extracellular vesicle studies. Again, welcome to Barcelona! On behalf of the International Organizing Committee, Juan Falcón-Pérez Chair, International Organizing Committee Annual Meeting — ISEV2018 | Barcelona, Spain | 2–6 May 2018 4 About the International Society for Extracellular Vesicles ISEV is a global society of researchers and scientists studying exosomes and microvesicles. With over 1,000 members, ISEV is the leading advocate and guide of extracellular vesicle research with a mission of advancing extracellular vesicle research globally. ISEV Executive Board and Board of Directors 2016-2018 President Executive Chair, Communications Carolina Soekmadji Andrew Hill Dolores Di Vizio Australia Australia United States Secretary General Past President Hidetoshi Tahara Asia Pacific Kenneth Witwer Jan Lötvall United States Sweden Treasurer Chair International Organizing Committee Ana Claudia Torrecilhas Brazil Chris Gardiner United Kingdom Juan Falcón-Pérez Spain Executive Chair, Science/Meetings Alissa Weaver Members at Large United States Marca Wauben The Netherlands Rienk Nieuwland Executive Chair, Education Hubert Yin The Netherlands China/United States Edit Buzas Hungary Susmita Sahoo Lei Zheng United States China Annual Meeting — ISEV2018 | Barcelona, Spain | 2–6 May 2018 5 2018 International Organizing Committee Members Juan Falcón-Pérez, PhD Isabel Guerrero Hidetoshi Tahara IOC Chair UAM/CBM-SO Hiroshima University CIC bioGUNE Madrid, Spain Hiroshima, Japan Bizkaia, Spain Andrew Hill Marca Wauben Hernando A. del Portillo ISEV President Utrecht University GEIVEX President La Trobe University Utrecht, The Netherlands ICREA at ISGlobal and IGTP Melbourne Australia Barcelona, Spain Kenneth Witwer Antonio Marcilla Johns Hopkins University Francesc Borrás Universitat de València Baltimore, MD USA "Germans Trias i Pujol" Research Institute Valencia, Spain (IGTP),Can Ruti Campus Barcelona, Spain María Yáñez-Mó Héctor Peinado UAM/CBM-SO Spanish National Cancer Madrid, Spain Edit Buzas Research Center – CNIO Semmelweis University Madrid, Spain Budapest, Hungary Hubert Yin Colorado University Susmita Sahoo Boulder, Colorado Dolores DiVizio Mount Sinai School of Medicine Cedars-Sinai Medical Center New York, NY USA Los Angeles, CA USA Annual Meeting — ISEV2018 | Barcelona, Spain | 2–6 May 2018 6 Hall 5 Montjuïc ROOM 9 41 sqm LEVEL 4 OFFICES 16 sqm each (X2) Auditorium ROOM 7 ROOM 5 1362 sqm 277 sqm Palau deHall Congressos 5 ROOM Barcelona 8 –Hall Fira 5 Montjuic 150 sqm ROOM 3 Floor PlanLEVEL 3 Montjuïc ROOM 6 183 sqm Halls and open areas ROOM 9 310 sqm Enclosed rooms ROOMS 1 and 2 41 sqm LEVEL 4 39 sqm each Elevators OFFICES Restrooms 16 sqm each (X2) Auditorium ROOM 7 ROOM 5 Catering outlet ROOM 4 Hall 5 1362 sqm 277 sqm Desk/ cloakroom 108 sqm Hall 5 ROOM 8 LEVEL 2 Montjuïc 150 sqm ROOM 3 VIP AREA ROOM 9 Public Access LEVEL 3 183 sqm 341 sqm 41 sqm ROOM 6 Halls and open areas 528 528 sqm LEVEL 4 310 sqm height 5,69m ROOMS 1 and 2 Enclosed rooms OFFICES 39 sqm each Elevators 16 sqm each (X2) Auditorium ROOM 7 Restrooms ROOM 5 Public Access 1362 sqm LEVEL 1 Catering outlet 277 sqm ROOM 4 Hall 5 ROOM 8 street level Desk/ cloakroom 108 sqm 150 sqm 2,28 sqm ROOM 3 LEVELheight 2 5,36m LEVEL 3 1,95 sqm ROOM 6 183 sqm VIP AREA height 2,0m Public Access Halls and open areas 310 sqm 341 sqm Enclosed rooms ROOMS 1 and 2 528 528 sqm height 5,69m 39 sqm each ROOMS 11 and12 Elevators 124 and 138 sqm Restrooms LEVEL 0 Public Access Catering outlet ROOM 4 LEVEL 1 Desk/ cloakroom 108 sqm street level 2,28 sqm LEVEL 2 height 5,36m 1,95 sqm VIP AREA Public Access height 2,0m 341 sqm 528 528 sqm height 5,69m ROOMS 11 and12 124 and 138 sqm Public Access LEVEL 0 LEVEL 1 street level 2,28 sqm height 5,36m 1,95 sqm height 2,0m ROOMS 11 and12 124 and 138 sqm LEVEL 0 Annual Meeting — ISEV2018 | Barcelona, Spain | 2–6 May 2018 7 Acknowledgements ISEV gratefully acknowledges the support of the 2018 Annual Conference from our Sponsors: PLATINUM SILVER BRONZE LANYARD SPONSOR NOTEPAD SPONSOR EXHIBITORS Annual Meeting — ISEV2018 | Barcelona, Spain | 2–6 May 2018 8 General Information Abstracts Exhibits Abstracts for plenary and parallel sessions are Educational and informational exhibits will be included in the Abstract Book, which is available available for viewing during the Annual Meeting for download from the conference website: and representatives will be on hand to answer http://www.isev.org/page/ISEV2018homepage.
Load more

Recommended publications
  • Attenuation of Pathogenic Immune Responses During Infection with Human and Simian Immunodeficiency Virus (HIV/SIV) by the Tetracycline Derivative Minocycline
    Attenuation of Pathogenic Immune Responses during Infection with Human and Simian Immunodeficiency Virus (HIV/SIV) by the Tetracycline Derivative Minocycline Julia L. Drewes1, Gregory L. Szeto1¤, Elizabeth L. Engle1, Zhaohao Liao1, Gene M. Shearer2,M. Christine Zink1*, David R. Graham1,3* 1 Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, 2 Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, 3 Johns Hopkins Bayview Proteomics Center, Department of Medicine, Division of Cardiology, Johns Hopkins School of Medicine Bayview Campus, Baltimore, Maryland, United States of America Abstract HIV immune pathogenesis is postulated to involve two major mechanisms: 1) chronic innate immune responses that drive T cell activation and apoptosis and 2) induction of immune regulators that suppress T cell function and proliferation. Both arms are elevated chronically in lymphoid tissues of non-natural hosts, which ultimately develop AIDS. However, these mechanisms are not elevated chronically in natural hosts of SIV infection that avert immune pathogenesis despite similarly high viral loads. In this study we investigated whether minocycline could modulate these pathogenic antiviral responses in non-natural hosts of HIV and SIV. We found that minocycline attenuated in vitro induction of type I interferon (IFN) and the IFN-stimulated genes indoleamine 2,3-dioxygenase (IDO1) and TNF-related apoptosis inducing ligand (TRAIL) in human plasmacytoid dendritic cells and PBMCs exposed to aldrithiol-2 inactivated HIV or infectious influenza virus. Activation- induced TRAIL and expression of cytotoxic T-lymphocyte antigen 4 (CTLA-4) in isolated CD4+ T cells were also reduced by minocycline.
    [Show full text]
  • University of Groningen Mechanics of Extracellular Vesicles
    University of Groningen Mechanics of extracellular vesicles derived from malaria parasiteinfected Red Blood Cells Sorkin, Raya; Vorselen, Daan; Ofir-Birin, Yifat; Roos, Wouter H.; MacKintosh, Fred C.; Regev-Rudzki, Neta; Wuite, Gijs J. L. Published in: Journal of Extracellular Vesicles DOI: 10.3402/jev.v5.31552 IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Publication date: 2016 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Sorkin, R., Vorselen, D., Ofir-Birin, Y., Roos, W. H., MacKintosh, F. C., Regev-Rudzki, N., & Wuite, G. J. L. (2016). Mechanics of extracellular vesicles derived from malaria parasiteinfected Red Blood Cells. Journal of Extracellular Vesicles, 5, 86. https://doi.org/10.3402/jev.v5.31552 Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 12-11-2019
    [Show full text]
  • Human Perivascular Stem Cell-Derived Extracellular Vesicles Mediate Bone
    RESEARCH ARTICLE Human perivascular stem cell-derived extracellular vesicles mediate bone repair Jiajia Xu1, Yiyun Wang1, Ching-Yun Hsu1, Yongxing Gao1, Carolyn Ann Meyers1, Leslie Chang1, Leititia Zhang1,2, Kristen Broderick3, Catherine Ding4, Bruno Peault4,5,6, Kenneth Witwer7,8, Aaron Watkins James1* 1Department of Pathology, Johns Hopkins University, Baltimore, United States; 2Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, Shenyang, China; 3Department of Surgery, Johns Hopkins University, Baltimore, United States; 4Department of Orthopaedic Surgery, Orthopaedic Hospital Research Center, UCLA, Orthopaedic Hospital, Los Angeles, United States; 5Centre For Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; 6MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom; 7Department of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, United States; 8Department of Neurology, Johns Hopkins University, Baltimore, United States Abstract The vascular wall is a source of progenitor cells that are able to induce skeletal repair, primarily by paracrine mechanisms. Here, the paracrine role of extracellular vesicles (EVs) in bone healing was investigated. First, purified human perivascular stem cells (PSCs) were observed to induce mitogenic, pro-migratory, and pro-osteogenic effects on osteoprogenitor cells while in non- contact co-culture via elaboration of EVs. PSC-derived EVs shared mitogenic, pro-migratory, and pro-osteogenic properties of their parent cell. PSC-EV effects were dependent on surface- associated tetraspanins, as demonstrated by EV trypsinization, or neutralizing antibodies for CD9 or CD81. Moreover, shRNA knockdown in recipient cells demonstrated requirement for the CD9/ CD81 binding partners IGSF8 and PTGFRN for EV bioactivity. Finally, PSC-EVs stimulated bone repair, and did so via stimulation of skeletal cell proliferation, migration, and osteodifferentiation.
    [Show full text]
  • Announcing the ISEV2020 Special Achievement Award Recipients
    Thomas Jefferson University Jefferson Digital Commons Kimmel Cancer Center Faculty Papers Kimmel Cancer Center 10-1-2020 Announcing the ISEV2020 special achievement award recipients: Andrew Hill and Edit Buzás; and the recipient of the ISEV2020 special education award: Carolina Soekmadji. Kenneth W Witwer Lucia R Languino Alissa M Weaver Marca H Wauben Follow this and additional works at: https://jdc.jefferson.edu/kimmelccfp Part of the Oncology Commons Let us know how access to this document benefits ouy This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Kimmel Cancer Center Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact: [email protected]. Received: 30 July 2020 Accepted: 8 September 2020 DOI: 10.1002/jev2.12021 EDITORIAL Announcing the ISEV special achievement award recipients: AndrewHillandEditBuzás;andtherecipientoftheISEV special education award: Carolina Soekmadji The International Society for Extracellular Vesicles (ISEV) is pleased to announce two Special Achievement Awards that were presented at the virtual ISEV2020 annual meeting, 20–22 July 2020. ISEV Special Achievement Awards are given each year to one or more individuals who have made outstanding contributions to the field of extracellular vesicle (EV) research or have per- formed extraordinary service to ISEV (Witwer, Hill, & Tahara, 2019).
    [Show full text]
  • Isct2021 Program
    MAY 26–28 ISCT2021 VIRTUAL Orchestrating Global CGT Translation Building Consensus for the Path Forward PROGRAM MAY 26–28 ISCT2021 VIRTUAL WELCOME FROM THE ISCT PRESIDENT Dear Friends and Colleagues, a day, 3 concurrent tracks), and all of which will be available for viewing on demand for the remainder of 2021. Extra effort We ARE friends AND colleagues! Just as ISCT is a Society has been invested for enhanced virtual Networking, with a full like no other, ISCT 2021 Virtual New Orleans will continue ISCT 2021 Networking Day on May 25. During the Networking our breakthrough last year in providing a virtual platform Day, you can attend the inaugural Investigators to Investors with industry leading presentation technology that is im- (I to I) Workshop, organized by the ISCT Business Models & mersive and informative, enlightening and engaging in a Investment Commercialization Sub-Committee, which will multi-dimensional platform that reflects our Society values. bring together cell and gene therapy investors for a half-day We promote innovation in translational research. We strive educational event providing unparalleled access to cell and for excellence in everything we do. We respect and support gene therapy key opinion leaders. diversity and inclusivity. We uphold the highest ethical stan- dards. We serve our members and advocate for our Society. The anchor for your ISCT program is the six plenary ses- sions. Leading off, our President Elect Jacques Galipeau Over the past year, the world has seen great tragedy and will chair the plenary “COVID-19: Understanding the Path scientific advances to meet pandemic challenges. The field Forward for Mesenchymal Stromal Cell Therapies.” For the of cell and gene therapy continues to break new ground, Presidential Plenary, representing the Commercialization advancing medical care for patients worldwide.
    [Show full text]
  • Extracellular Vesicles and Nanoerythrosomes: the Hidden Pearls of Blood Products
    Academic Dissertations from The Finnish Red Cross Blood Service number 64 SAMI VALKONEN | Extracellular Vesicles and Nanoerythrosomes: The Hidden Pearls of Blood Products Blood Nanoerythrosomes: Pearls of Extracellular and Hidden The | Vesicles SAMI VALKONEN SAMI VALKONEN Extracellular Vesicles and Nanoerythrosomes: The Hidden Pearls of Blood Products ISBN 978-952-5457-48-3 (print) ISBN 978-952-5457-49-0 (pdf) ISSN 1236-0341 FRC BS: 64 http://ethesis.helsinki.fi Turku 2019 Painosalama Oy ACADEMIC DISSERTATION, NUMBER 64 Doctoral School of Health Sciences Doctoral Programme in Biomedicine Molecular and Integrative Biosciences Research Programme Faculty of Biological and Environmental Sciences University of Helsinki and Finnish Red Cross Blood Service EXTRACELLULAR VESICLES AND NANOERYTHROSOMES: THE HIDDEN PEARLS OF BLOOD PRODUCTS Sami Valkonen ACADEMIC DISSERTATION To be presented for public examination, with the permission of the Faculty of Biological and Environmental Sciences of the University of Helsinki, in Nevanlinna Auditorium of the Finnish Red Cross Blood Service, Kivihaantie 7, Helsinki, on 19th December 2019, at 12 noon. Helsinki 2019 ACADEMIC DISSERTATIONS FROM THE FINNISH RED CROSS BLOOD SERVICE, NUMBER 64 Supervisors Adjunct Professor Pia Siljander Faculty of Biological and Environmental Sciences University of Helsinki Doctor Saara Laitinen Department of Research & Development Finnish Red Cross Blood Service Thesis Committee Associate Professor Susanna Fagerholm Faculty of Biological and Environmental Sciences University of
    [Show full text]
  • Downloaded From
    Canonical Type I IFN Signaling in Simian Immunodeficiency Virus-Infected Macrophages Is Disrupted by Astrocyte-Secreted CCL2 This information is current as of September 27, 2021. Luna Alammar Zaritsky, Lucio Gama and Janice E. Clements J Immunol published online 9 March 2012 http://www.jimmunol.org/content/early/2012/03/09/jimmun ol.1103024 Downloaded from Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published March 9, 2012, doi:10.4049/jimmunol.1103024 The Journal of Immunology Canonical Type I IFN Signaling in Simian Immunodeficiency Virus-Infected Macrophages Is Disrupted by Astrocyte-Secreted CCL2 Luna Alammar Zaritsky,* Lucio Gama,* and Janice E. Clements*,† HIV-associated neurologic disorders are a mounting problem despite the advent of highly active antiretroviral therapy. To address mechanisms of HIV-associated neurologic disorders, we used an SIV pigtailed macaque model to study innate immune responses in brain that suppress viral replication during acute infection.
    [Show full text]
  • NCUR Proceedings
    NCUR 2021 Proceedings A Diffusion Approach for Plasma Synthesis of Superhard Tantalum Borides Physics/Astronomy - Time: Tue 3:30pm-4:30pm - Session Number: 745 Aaditya Rau, Dr. Aaron Catledge, Department of Physics, The University of Alabama at Birmingham, 1720 2nd Ave S, Birmingham, Alabama 35294 Aaditya Rau Tantalum borides are a set of refractory metal compounds that have become of interest due to their desirable mechanical, thermal, and electrical properties. While these compounds have been previously synthesized in a variety of methods, key issues related to sample size, sample integrity, and implementation feasibility limit their use. In this study, a microwave plasma chemical vapor deposition (MPCVD) reactor was used to diffuse boron into tantalum substrates using a feedgas mixture of hydrogen and diborane. Specifically, the role of substrate temperature and substrate bias in influencing the chemical composition and mechanical properties of the borided tantalum was investigated. X-ray diffraction shows that high substrate temperature is favorable for TaB2 formation, with samples made at great than 775°C having a mean surface hardness of 40 GPa along with increased strain in the tantalum body-centered cubic lattice. Once the strained tantalum becomes locally supersaturated with boron, TaB and TaB2 precipitate. The combination of precipitation hardening as well as solid solution hardening may help explain the measured superhardness, as measured by nanoindentation. Application of a negative bias voltage to the substrate during the CVD process was not found to further increase the hardness, and in some cases decreased the measured hardness significantly, possibly due to etching effects from increased ion bombardment. These results show that MPCVD is a viable method for synthesis of superhard borides based on plasma-assisted diffusion.
    [Show full text]
  • Pharmacokinetics and Biodistribution of Extracellular Vesicles Administered Intravenously and Intranasally to Macaca Nemestrina
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.28.454192; this version posted July 29, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina Authors Tom Driedonks1, Linglei Jiang1, Bess Carlson 1, Zheng Han2,3, Guanshu Liu2,3, Suzanne E. Queen1, Erin N. Shirk1, Olesia Gololobova1, Lyle Nyberg1, Gabriela Lima1, Kayla Schonvisky1, Natalie Castell1, Mitchel Stover, Selena Guerrero-Martin1,4, Riley Richardson1, Barbara Smith5, Charles P. Lai6, Jessica M. Izzi1, Eric K. Hutchinson1, Kelly A.M. Pate1,4, Kenneth W. Witwer1,7,8,* 1. Dept. Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, US 2. Russell H. Morgan Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, US 3. F.M. Kirby Research Center, Kennedy Krieger Institute, Baltimore, MD, US 4. Division of ComParative Medicine and DePartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, US 5. DePt. Cell Biology, Johns HoPkins University School of Medicine, Baltimore, MD, US 6. Institute of Atomic and Molecular Sciences, Academia Sinica, TaiPei, Taiwan 7. DePt. of Neurology, Johns HoPkins University School of Medicine, Baltimore, MD, US 8. The Richman Family Precision Medicine Center of Excellence in Alzheimer’s Disease, Johns Hopkins University School of Medicine, Baltimore, MD, US *CorresPondence: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.07.28.454192; this version posted July 29, 2021.
    [Show full text]
  • Highlights of the São Paulo ISEV Workshop on Extracellular Vesicles in Cross-Kingdom Communication
    Journal of Extracellular Vesicles ISSN: (Print) 2001-3078 (Online) Journal homepage: http://www.tandfonline.com/loi/zjev20 Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication Rodrigo P. Soares, Patrícia Xander, Adriana Oliveira Costa, Antonio Marcilla, Armando Menezes-Neto, Hernando Del Portillo, Kenneth Witwer, Marca Wauben, Esther Nolte-`T Hoen, Martin Olivier, Miriã Ferreira Criado, Luis Lamberti P. da Silva, Munira Muhammad Abdel Baqui, Sergio Schenkman, Walter Colli, Maria Julia Manso Alves, Karen Spadari Ferreira, Rosana Puccia, Peter Nejsum, Kristian Riesbeck, Allan Stensballe, Eline Palm Hansen, Lorena Martin Jaular, Reidun Øvstebø, Laura de la Canal, Paolo Bergese, Vera Pereira-Chioccola, Michael W. Pfaffl, Joëlle Fritz, Yong Song Gho & Ana Claudia Torrecilhas To cite this article: Rodrigo P. Soares, Patrícia Xander, Adriana Oliveira Costa, Antonio Marcilla, Armando Menezes-Neto, Hernando Del Portillo, Kenneth Witwer, Marca Wauben, Esther Nolte- `T Hoen, Martin Olivier, Miriã Ferreira Criado, Luis Lamberti P. da Silva, Munira Muhammad Abdel Baqui, Sergio Schenkman, Walter Colli, Maria Julia Manso Alves, Karen Spadari Ferreira, Rosana Puccia, Peter Nejsum, Kristian Riesbeck, Allan Stensballe, Eline Palm Hansen, Lorena Martin Jaular, Reidun Øvstebø, Laura de la Canal, Paolo Bergese, Vera Pereira-Chioccola, Michael W. Pfaffl, Joëlle Fritz, Yong Song Gho & Ana Claudia Torrecilhas (2017) Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication, Journal of Extracellular Vesicles, 6:1, 1407213, DOI: 10.1080/20013078.2017.1407213 To link to this article: https://doi.org/10.1080/20013078.2017.1407213 © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
    [Show full text]
  • Summary of the ISEV Workshop on Extracellular Vesicles As Disease Biomarkers, Held in Birmingham, UK, During December 2017
    Journal of Extracellular Vesicles ISSN: (Print) 2001-3078 (Online) Journal homepage: https://www.tandfonline.com/loi/zjev20 Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017 Aled Clayton, Dominik Buschmann, J. Brian Byrd, David R. F. Carter, Lesley Cheng, Carolyn Compton, George Daaboul, Andrew Devitt, Juan Manuel Falcon-Perez, Chris Gardiner, Dakota Gustafson, Paul Harrison, Clemens Helmbrecht, An Hendrix, Andrew Hill, Andrew Hoffman, Jennifer C. Jones, Raghu Kalluri, Ji Yoon Kang, Benedikt Kirchner, Cecilia Lässer, Charlotte Lawson, Metka Lenassi, Carina Levin, Alicia Llorente, Elena S. Martens- Uzunova, Andreas Möller, Luca Musante, Takahiro Ochiya, Ryan C Pink, Hidetoshi Tahara, Marca H. M. Wauben, Jason P. Webber, Joshua A. Welsh, Kenneth W. Witwer, Hang Yin & Rienk Nieuwland To cite this article: Aled Clayton, Dominik Buschmann, J. Brian Byrd, David R. F. Carter, Lesley Cheng, Carolyn Compton, George Daaboul, Andrew Devitt, Juan Manuel Falcon-Perez, Chris Gardiner, Dakota Gustafson, Paul Harrison, Clemens Helmbrecht, An Hendrix, Andrew Hill, Andrew Hoffman, Jennifer C. Jones, Raghu Kalluri, Ji Yoon Kang, Benedikt Kirchner, Cecilia Lässer, Charlotte Lawson, Metka Lenassi, Carina Levin, Alicia Llorente, Elena S. Martens-Uzunova, Andreas Möller, Luca Musante, Takahiro Ochiya, Ryan C Pink, Hidetoshi Tahara, Marca H. M. Wauben, Jason P. Webber, Joshua A. Welsh, Kenneth W. Witwer, Hang Yin & Rienk Nieuwland (2018) Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017, Journal of Extracellular Vesicles, 7:1, 1473707, DOI: 10.1080/20013078.2018.1473707 To link to this article: https://doi.org/10.1080/20013078.2018.1473707 © 2018 The Author(s).
    [Show full text]
  • Summary of the ISEV Workshop on Extracellular Vesicles As Disease Biomarkers, Held in Birmingham, UK, During December 2017
    Journal of Extracellular Vesicles ISSN: (Print) 2001-3078 (Online) Journal homepage: http://www.tandfonline.com/loi/zjev20 Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017 Aled Clayton, Dominik Buschmann, J. Brian Byrd, David R. F. Carter, Lesley Cheng, Carolyn Compton, George Daaboul, Andrew Devitt, Juan Manuel Falcon-Perez, Chris Gardiner, Dakota Gustafson, Paul Harrison, Clemens Helmbrecht, An Hendrix, Andrew Hill, Andrew Hoffman, Jennifer C. Jones, Raghu Kalluri, Ji Yoon Kang, Benedikt Kirchner, Cecilia Lässer, Charlotte Lawson, Metka Lenassi, Carina Levin, Alicia Llorente, Elena S. Martens- Uzunova, Andreas Möller, Luca Musante, Takahiro Ochiya, Ryan C Pink, Hidetoshi Tahara, Marca H. M. Wauben, Jason P. Webber, Joshua A. Welsh, Kenneth W. Witwer, Hang Yin & Rienk Nieuwland To cite this article: Aled Clayton, Dominik Buschmann, J. Brian Byrd, David R. F. Carter, Lesley Cheng, Carolyn Compton, George Daaboul, Andrew Devitt, Juan Manuel Falcon-Perez, Chris Gardiner, Dakota Gustafson, Paul Harrison, Clemens Helmbrecht, An Hendrix, Andrew Hill, Andrew Hoffman, Jennifer C. Jones, Raghu Kalluri, Ji Yoon Kang, Benedikt Kirchner, Cecilia Lässer, Charlotte Lawson, Metka Lenassi, Carina Levin, Alicia Llorente, Elena S. Martens-Uzunova, Andreas Möller, Luca Musante, Takahiro Ochiya, Ryan C Pink, Hidetoshi Tahara, Marca H. M. Wauben, Jason P. Webber, Joshua A. Welsh, Kenneth W. Witwer, Hang Yin & Rienk Nieuwland (2018) Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017, Journal of Extracellular Vesicles, 7:1, 1473707, DOI: 10.1080/20013078.2018.1473707 To link to this article: https://doi.org/10.1080/20013078.2018.1473707 © 2018 The Author(s).
    [Show full text]